報價延遲最少15分鐘:2025/01/21 08:56 EST
|
|
|
|
|
||||||||||||
|
|
|
|
|
-- 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
5.24/9.19
|
|
企業價值
26.68B
|
| 資產負債 |
|
每股賬面淨值
62.16
|
| 現金流量 |
|
現金流量率
0.07
|
| 損益表 |
|
收益
7.39B
|
|
每股收益
36.57
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2025/01/21 08:56 EST
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022. |